Chinese vitamin C makers off the hook for U.S. antitrust violations
Oct 19, 2016
Following a dismissal by a U.S. appeals court of a $147 million price-fixing judgment, Chinese lawyers say that the my-government-made-me-do-it antitrust defense may not work next time for PRC companies
X
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
Last month, a three-judge panel of the U.S. Court of Appeals for the Second Circuit vacateda $147 million lower court verdict and freed a Chinese pharmaceutical maker from U.S. antitrust liability for price-fixing on the basis of international comity.
This premium content is reserved for China Law & Practice Subscribers.
A Premium Subscription Provides:
A database of over 3,000 essential documents including key PRC legislation translated into English
A choice of newsletters to alert you to changes affecting your business including sector specific updates
Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment